Anti-Cyclin D1 antibody [EPR2241] - C-terminal
- 20ul selling size
- BOND RX™ Validated
- KO Validated
- RabMAb
- Recombinant
- Lab Essentials
- What is this?
5
(15 Reviews)
|
(957 Publications)
Anti-Cyclin D1 antibody [EPR2241] - C-terminal (ab134175) is a rabbit monoclonal antibody detecting Cyclin D1 in Western Blot, IP, IHC-P, ICC/IF. Suitable for Human, Mouse, Rat.
- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 780 publications
View Alternative Names
BCL1, PRAD1, CCND1, G1/S-specific cyclin-D1, B-cell lymphoma 1 protein, BCL-1 oncogene, PRAD1 oncogene, BCL-1
- WB
Lab
Western blot - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)
Western blot : Anti-CCND1 antibody [EPR2241] (ab134175) staining at 1/10000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab134175 was shown to bind specifically to CCND1. A band was observed at 34 kDa in wild-type A549 cell lysates with no signal observed at this size in CCND1 knockout cell line. To generate this image, wild-type and CCND1 knockout A549 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (ab134175) at 1/10000 dilution
Lane 1:
Wild-type A549 cell lysate at 20 µg
Lane 2:
CCND1 knockout A549 cell lysate at 20 µg
Lane 2:
Western blot - Human CCND1 knockout A549 cell line (<a href='/en-us/products/cell-lines/human-ccnd1-knockout-a549-cell-line-ab286759'>ab286759</a>)
Lane 3:
SH-SY5Y cell lysate at 20 µg
Lane 4:
K562 cell lysate at 20 µg
false
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)
Immunofluorescent staining of Ramos (Human Burkitt's lymphoma cell line) cells (fixed in 4% PFA, permeabilized with 0.1% Triton X 100) using purified ab134175 at a dilution of 1/50. An Alexa Fluor® 488 goat anti-rabbit antibody was used as the secondary at a dilution of 1/500 and the cells were counterstained with DAPI.
The negative control is shown in the bottom right hand panel - for the negative control, Alex Fluor® 594 goat anti-mouse was used at a dilution of 1/500.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)
IHC image of ab134175 staining Cyclin D1 in human esophagus formalin fixed paraffin embedded tissue sections*, performed on a Leica Bond. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab134175, 5μg/ml working concentration, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with hematoxylin and mounted with DPX. No primary antibody was used in the secondary only control (shown on the inset).
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
*Tissue obtained from the Human Research Tissue Bank, supported by the NIHR Cambridge Biomedical Research Centre
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)
Immunohistochemical staining of paraffin embedded human endometrial adenocarcinoma with purified ab134175 at a dilution of 1/100. An HRP goat anti-rabbit (ab97051) was used as the secondary antibody at a dilution of 1/500 and the sample was counterstained with hematoxylin. Antigen retrieval was perfomed using Tris-EDTA buffer, pH 9.0.
PBS was used instead of the primary antibody as the negative control (inset).
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)
Unpurified ab134175 staining Cyclin D1 in MCF7 (Human breast adenocarcinoma cell line) cells treated with KN-93 (ab120980).
The cells were fixed with 100% methanol (5min) and then blocked in 1% BSA/10% normal goat serum/0.3M glycine in 0.1%PBS-Tween for 1h. The cells were then incubated with ab134175 at 10μg/ml and ab7291 at 1μg/ml overnight at +4°C, followed by a further incubation at room temperature for 1h with an Goat anti-Rabbit Alexa 488 secondary (ab150081) at 2 μg/ml (shown in green) and Goat anti-Mouse Alexa 594 secondary (ab150120) at 2 μg/ml (shown in pseudo color red). Nuclear DNA was labeled in blue with DAPI.
Negative controls : 1– Rabbit primary and anti-mouse secondary antibody; 2 – Mouse primary antibody and anti-rabbit secondary antibody. Controls 1 and 2 indicate that there is no unspecific reaction between primary and secondary antibodies used.
- IHC-P
PubMed
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)
Immunohistochemistry was performed on human head and neck squamous cell carcinoma tissue using a rabbit monoclonal antibody against the CCND1 protein ab134175 on 3-μm slides using 224 paraffin sections via the standard SP method.
Panel C : An example of low Cyclin D1 expression.
Panel G : An example of high Cyclin D1 expression.
For full image please see paper.
Feng et al PLoS One. 2011;6(10):e26399. doi: 10.1371/journal.pone.0026399. Epub 2011 Oct 31. Fig 1. Reproduced under the Creative Commons license http://creativecommons.org/licenses/by/4.0/
- ICC/IF
AbReview40418****
Immunocytochemistry/ Immunofluorescence - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)
Immunocytochemical analysis of HeLa (Human epithelial cell line from cervix adenocarcinoma) cells, labeling Cyclin D1 with ab134175 at a dilution of 1/200. Cells were paraformaldehyde fixed and permeabilized with 0.5% Triton X-100 in PBS. Incubation with the primary antibody was for 1 hour at 22°C. Cells were counterstained with DAPI following immunostaining.
This image is courtesy of an Abreview submitted by Kirk Mcmanus.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)
Immunohistochemical analysis of paraffin-embedded human mantle cell lymphoma tissue, labeling Cyclin D1 with unpurified ab134175 at 1/100 dilution.
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)
Immunohistochemical analysis of formalin fixed paraffin embedded human tonsil labelling Cyclin D1 with ab134175 at a concentration of 1 µg/ml. The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with a OptiView DAB IHC Detection Kit. Heat mediated antigen retrieval was performed with DISCOVERY cell conditioning solution (CC1) 100°C, pH8.5 for 32mins.
Anti-Cyclin D1 antibody [EPR2241] ab134175 was incubated for 16mins at 37°C. Sections were counterstained with Hematoxylin II. Image inset shows absence of staining in secondary antibody only control.
Customers are encouraged to optimise antigen retrieval conditions, antibody concentration, incubation times and temperature for best results in their own IHC assay workflow (automated and manual).
- IP
Lab
Immunoprecipitation - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)
ab134175 (purified) at 1/30 immunoprecipitating cyclin D1 in A431 (Human epidermoid carcinoma cell line) cells. For western blotting, an HRP-conjugated goat anti-rabbit IgG, was used as the secondary antibody (1/1000).
Blocking/Dilution buffer and concentration : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (ab134175)
Predicted band size: 34 kDa
false
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)
IHC image of ab134175 staining Cyclin D1 in rat esophagus formalin fixed paraffin embedded tissue sections, performed on a Leica Bond. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab134175, 5μg/ml working concentration, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with hematoxylin and mounted with DPX. No primary antibody was used in the secondary only control (shown on the inset).
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
- WB
Lab
Western blot - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (ab134175) at 1/100000 dilution
Lane 1:
MCF7 (Human breast adenocarcinoma cell line) cell lysate at 20 µg
Lane 2:
LNCap (Human prostate cancer cell line) cell lysate at 20 µg
Secondary
All lanes:
HRP goat anti-rabbit (H+L) at 1/1000 dilution
Predicted band size: 34 kDa
Observed band size: 34 kDa
false
- WB
Unknown
Western blot - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)
MG-63 cells were incubated at 37°C for 24h with vehicle control (0 μM) and different concentrations of 3-aminobenzamide (3-AB) (ab141069). Decreased expression of cyclin D1 (unpurified ab134175) in MG-63 cells correlates with an increase in 3-aminobenzamide (3-AB) concentration, as described in literature.
Whole cell lysates were prepared with RIPA buffer (containing protease inhibitors and sodium orthovanadate), 10 μg of each were loaded on the gel and the WB was run under reducing conditions. After transfer the membrane was blocked for an hour using 5% BSA before being incubated with unpurified ab134175 at 1/500 dilution and ab8226 at 1 μg/ml overnight at 4°C. Antibody binding was detected using an anti-rabbit HRP secondary antibody (ab97051) at 1/10000 dilution and visualised using ECL development solution.
All lanes:
Western blot - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (ab134175)
Predicted band size: 34 kDa
true
Exposure time: 3min
- WB
Lab
Western blot - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (ab134175) at 1/20000 dilution
Lane 1:
HeLa (Human epithelial cell line from cervix adenocarcinoma) cell lysate at 20 µg
Lane 2:
A431 (Human epidermoid carcinoma cell line) cell lysate at 20 µg
Secondary
All lanes:
HRP goat anti-rabbit (H+L) at 1/1000 dilution
Predicted band size: 34 kDa
Observed band size: 34 kDa
false
- WB
Lab
Western blot - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (ab134175) at 1/10000 dilution
Lane 1:
Mouse kidney at 20 µg
Lane 2:
Mouse spleen at 20 µg
Lane 3:
Rat heart at 20 µg
Secondary
All lanes:
HRP goat anti-rabbit (H+L) at 1/1000 dilution
Predicted band size: 34 kDa
Observed band size: 34 kDa
false
- WB
Lab
Western blot - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)
Blocking and dilution buffer : 5% NFDM/TBST.
Lane 1:
Western blot - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (ab134175) at 0.04 µg/mL
Lane 2:
Western blot - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (ab134175) at 2 µg/mL
Lane 1:
His-Tagged full-length human Cyclin D1 (aa 1 to 295) recombinant protein at 0.015 µg
Lane 2:
His-Tagged full-length human Cyclin D2 (aa 1 to 289) recombinant protein at 0.015 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 34 kDa
Observed band size: 37 kDa
false
Exposure time: 3min
- OI-RD Scanning
Unknown
OI-RD Scanning - Anti-Cyclin D1 antibody [EPR2241] - C-terminal (AB134175)
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
Related conjugates and formulations (6)
-
Anti-Cyclin D1 antibody [EPR2241] - BSA and Azide free
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-Cyclin D1 antibody [EPR2241]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-Cyclin D1 antibody [EPR2241]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-Cyclin D1 antibody [EPR2241]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-Cyclin D1 antibody [EPR2241]
-
HRP Anti-Cyclin D1 antibody [EPR2241]
Reactivity data
Product details
Product Specifications
Anti-Cyclin D1 antibody [EPR2241] - C-terminal (ab134175) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in ICC/IF, IHC-P, IP, WB in human, mouse, rat samples.
Anti-Cyclin D1 antibody [EPR2241] - C-terminal (ab134175) specifically detects Cyclin D1 (UniProt ID: P24385; Molecular weight: 34kDa) and is sold in 50 µL, 100 µL and 1 mL selling sizes.
Quality and Validation
Abcam's high quality manufacturing and validation processes ensure Anti-Cyclin D1 antibody [EPR2241] - C-terminal (ab134175) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.
The specificity of Anti-Cyclin D1 antibody [EPR2241] - C-terminal (ab134175) has been confirmed by testing in knockout samples.
Anti-Cyclin D1 antibody [EPR2241] - C-terminal (ab134175) has been cited over 783 times in peer reviewed journals and is trusted by the scientific community.
Anti-Cyclin D1 antibody [EPR2241] - C-terminal (ab134175) has 15 independent reviews from customers.
Related Products
Antibody clone EPR2241 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor® 488, Alexa Fluor® 647, HRP, Alexa Fluor® 594, Alexa Fluor® 555 (ab190194, ab190563, ab190564, ab203446, ab203448).
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (957)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in bioengineering and biotechnology 13:1641476 PubMed41069411
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cancer management and research 17:1989-1997 PubMed41019940
2025
Applications
Unspecified application
Species
Unspecified reactive species
OncoTargets and therapy 18:979-994 PubMed40934061
2025
Applications
Unspecified application
Species
Unspecified reactive species
Molecular and clinical oncology 23:95 PubMed40901568
2025
Applications
Unspecified application
Species
Unspecified reactive species
Materials today. Bio 34:102181 PubMed40893374
2025
Applications
Unspecified application
Species
Unspecified reactive species
Exploration (Beijing, China) 5:20240363 PubMed40873647
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cancer management and research 17:1657-1666 PubMed40837329
2025
Applications
Unspecified application
Species
Unspecified reactive species
American journal of cancer research 15:2949-2969 PubMed40814362
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 26: PubMed40806270
2025
Applications
Unspecified application
Species
Unspecified reactive species
BMC cancer 25:1313 PubMed40804612
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com